
Evolus EOLS
$ 4.44
2.54%
Annual report 2025
added 03-03-2026
Country |
|
IPO year |
2018 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
64.5 M |
Market Cap[1] |
$ 286 M |
EBITDA (LTM) |
$ -48.4 M |
P/E (LTM) |
-3.9 |
P/S (LTM) |
1.04 |
EPS (LTM) |
-1.11 |
Other stocks of industry "Drug manufacturers"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | ||
|
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | ||
|
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | ||
|
Catalent
CTLT
|
- | - | $ 11.5 B | NYSE,SPB | ||
|
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | ||
|
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB | ||
|
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | ||
|
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | ||
|
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | ||
|
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market | ||
|
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | ||
|
Cumberland Pharmaceuticals
CPIX
|
$ 3.18 | 1.92 % | $ 44.7 M | Nasdaq Global Select Market | ||
|
Cronos Group
CRON
|
$ 2.57 | - | $ 1.33 B | Nasdaq Global Market | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market | ||
|
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | ||
|
Bausch Health Companies
BHC
|
$ 5.68 | -0.7 % | $ 2.07 B | NYSE | ||
|
Harrow Health
HROW
|
$ 37.94 | 2.27 % | $ 1.39 B | Nasdaq Global Market | ||
|
Aurora Cannabis
ACB
|
$ 3.53 | 1.44 % | $ 86.3 M | NYSE | ||
|
Canopy Growth Corporation
CGC
|
$ 1.09 | 0.93 % | $ 117 M | Nasdaq Global Select Market | ||
|
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | ||
|
OrganiGram Holdings
OGI
|
$ 1.43 | 0.7 % | $ 402 M | Nasdaq Global Select Market | ||
|
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | ||
|
Sundial Growers
SNDL
|
$ 1.44 | 5.11 % | $ 3.37 M | Nasdaq Global Select Market | ||
|
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | ||
|
Emergent BioSolutions
EBS
|
$ 8.66 | 5.1 % | $ 443 M | NYSE,SPB | ||
|
Tilray
TLRY
|
$ 6.91 | 2.83 % | $ 4.27 B | Nasdaq Global Select Market | ||
|
Organogenesis Holdings
ORGO
|
$ 2.51 | 5.46 % | $ 330 M | Nasdaq Capital Market | ||
|
Pacira BioSciences
PCRX
|
$ 23.75 | -1.29 % | $ 1.1 B | Nasdaq Global Select Market,SPB | ||
|
Veru
VERU
|
$ 2.42 | 1.68 % | $ 326 M | Nasdaq Capital Market | ||
|
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | ||
|
Viatris
VTRS
|
$ 13.91 | 0.58 % | $ 16.7 B | Nasdaq Global Select Market,SPB | ||
|
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | ||
|
cbdMD
YCBD
|
$ 0.73 | -2.28 % | $ 3.15 M | NYSE American | ||
|
Relmada Therapeutics
RLMD
|
$ 7.19 | -2.57 % | $ 284 M | Nasdaq Global Select Market,SPB | ||
|
Assertio Holdings
ASRT
|
$ 18.02 | - | $ 115 M | Nasdaq Capital Market | ||
|
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | ||
|
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | ||
|
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | ||
|
SCYNEXIS
SCYX
|
$ 1.02 | 0.99 % | $ 50.9 M | Nasdaq Global Select Market | ||
|
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | ||
|
Solid Biosciences
SLDB
|
$ 8.23 | -1.91 % | $ 720 M | Nasdaq Global Select Market,SPB | ||
|
Sonoma Pharmaceuticals
SNOA
|
$ 2.18 | -7.23 % | $ 2.71 M | Nasdaq Capital Market | ||
|
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | ||
|
Zynerba Pharmaceuticals
ZYNE
|
- | - | $ 55.5 M | Nasdaq Global Market,SPB | ||
|
Rockwell Medical
RMTI
|
$ 0.93 | -1.38 % | $ 33.5 M | Nasdaq Global Market | ||
|
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | ||
|
China Pharma Holdings
CPHI
|
$ 0.63 | -3.05 % | $ 2.7 M | NYSE American | ||
|
TherapeuticsMD
TXMD
|
$ 2.11 | 2.93 % | $ 24.4 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.